Established in 1998, went public in May 2012, Dongcheng Biochemicals Co。,Ltd has developed into an enterprise group which combines ……
Dongcheng Pharmaceutical has continuously increased its investment in scientific research and is committed to independent innovation.
Dongcheng Pharmaceutical has continuously increased its investment in scientific research and is committed to independent innovation。
China's radiopharmaceutical industry is still in its infancy. In 2013, the output value of radio medicines nationwide was 2 billion yuan,
Service and Support
DCB now is one of the biggest biochemical API manufacturers in China, With leading production technology, reliable product quality and excellent international qualification background,
Care for life with sincerity, Continuous innovation, striving for perfection! In the future, DCB will carry on the mission of serving human health,
烟台东诚药业集团股份有限公司 Sponsored by China Chamber of Commerce of Medicines , lead the standard of biochemical API as w...
On November 29, 2018, Yantai FDA successfully organized and held the conference of s product obtai...
Stock code: 002675 Stock abbreviation: D。。。
The company is about to participate in t。。。